Skip to main navigation Skip to search Skip to main content

Descubrimiento de nuevos antimaláricos a partir de fármacos conocidos mediante cribado in silico e in vitro

Translated title of the contribution: Discovery of new antimalarials from commercial drugs by in silico and in vitro screening
  • Yanetsy Machado Tugores*
  • , Alfredo Meneses Marcel
  • , Yovani Marrero Ponce
  • , Vicente J. Aran
  • , José Antonio Escario García-Trevijano
  • , Huong Le Thi Thu
  • , Rory N. García Sánchez
  • , Alicia Gómez Barrio
  • *Corresponding author for this work
  • Universidad Central Marta Abreu de Las Villas
  • UCM
  • UCLV
  • Universitat de València
  • CSIC - Medicinal Chemistry Institute
  • Laboratorio de Investigación de Productos Naturales Antiparasitarios de la Amazonía

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

Increased efforts in antimalarial drug discovery are urgently needed. This paper applies a virtual screening protocol consisting of different computational filters in order to identify new antimalarial scaffolds from a structurally diverse library. This procedure has retained 38 new virtual hit which 12 were selected for experimental evaluation against Plasmodium falciparum, 3 of them showed significant antimalarial activity. These compounds have diverse chemical structures unrelated to existing antimalarial drugs can therefore be considered as new lead compounds, which leave an open door to the development of new antimalarials.

Translated title of the contributionDiscovery of new antimalarials from commercial drugs by in silico and in vitro screening
Original languageSpanish
Pages (from-to)401-416
Number of pages16
JournalAnales de la Real Academia Nacional de Farmacia
Volume78
Issue number4
StatePublished - 2012
Externally publishedYes

Fingerprint

Dive into the research topics of 'Discovery of new antimalarials from commercial drugs by in silico and in vitro screening'. Together they form a unique fingerprint.

Cite this